Skip to main content

Table 3 Adverse events recorded during the study

From: Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

Adverse events

DP (n, %)

AL (n, %)

Total (n, %)

Abdominal pain

9 (4.6)

9 (4.8)

18 (4.7)

Dizziness

5 (2.5)

2 (1.1)

7 (1.8)

Diarrhoea

4 (2)

2 (1.1)

6 (1.6)

Vomiting

4 (2)

0 (0)

4 (1)

Pruritus

3 (1.5)

1 (0.5)

4 (1)

Nausea

2 (1)

2 (1.1)

4 (1)

Face oedema

1 (0.5)

0 (0)

1 (0.3)

Sleepiness

1 (0.5)

0 (0)

1 (0.3)

Insomnia

0 (0)

1 (0.5)

1 (0.3)